X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: PhRMA’s comments on new direction for CMMI

By Nicole Longo  |    November 20, 2017
Today, PhRMA submitted its comments in response to the Centers for Medicare & Medicaid Services (CMS) request for information on the future of the Center for Medicare and Medicaid Innovation...   Read More

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI

By Nicole Longo  |    October 30, 2017
In case you missed it, earlier this month, the Center for Medicare & Medicaid Services formally withdrew a controversial proposal that would have had a detrimental impact on patient access to...   Read More

Medicare Monday: Have you heard of CMMI?

By Nicole Longo  |    February 20, 2017
There are a number of acronyms commonly used in the health care world, which can often be confusing and complicated, so this week we’re tackling one of them: CMMI.   Read More

Medicare Monday: How existing CMMI models affect Medicare Part B

By Kelsey Lang  |    November 7, 2016
Earlier this year the Center for Medicare & Medicaid Innovation (CMMI) proposed the Medicare Part B Drug Payment Model, also known as the Part B Demo, an experiment that would change how providers...   Read More

Medicare Monday: Concerns still abound about Part B proposal

By Allyson Funk  |    August 15, 2016
We’ve covered many of the concerns about the government’s overreaching proposal to change Medicare Part B payments and negatively impact seniors’ access to treatment. A lack of patient protections...   Read More

New Report: Part B proposal is more aggressive than previous efforts

By Kelsey Lang  |    June 1, 2016
In the more than 1,300 comments submitted to the Centers for Medicare & Medicaid Services (CMS) on the Part B Drug Payment Model, a wide range of organizations raised concern with the...   Read More

Medicare Monday: What they’re saying about the CMS proposed Part B payment model

By Nicole Longo  |    May 9, 2016
Voices throughout the media and health care system have raised concerns with the Part B Drug Payment Model proposed by the Centers for Medicare & Medicaid Services (CMS). News outlets have called...   Read More

Medicare Monday: Part B proposal lacks essential patient protections

By Kelsey Lang  |    May 2, 2016
We’ve highlighted how the proposed Part B model lacks safeguards to protect patients from barriers and reduced quality of care. Some stakeholders have suggested that the Part B proposal looks a...   Read More

New Research: Access and quality implications of CMS proposed Part B model

By Kelsey Lang  |    April 27, 2016
In recent weeks, providers and stakeholders across the health care system have raised concerns that the Part B Drug Payment Model proposed by the Centers for Medicare & Medicaid Services (CMS) lacks...   Read More

Medicare Monday: 3 things to know about the government’s Medicare payment change

By Allyson Funk  |    March 14, 2016
Last week, the Centers for Medicare & Medicaid Services (CMS) released a proposed demonstration through the Innovation Center to change how Medicare Part B drugs are reimbursed. Here are the three...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates